Nubeqa – Darolutamide
Oral: 600 mg twice daily (two pills twice a day).
Administer with food. Swallow tablets whole.
Feeling more tired than usual, rash, neutropenia, changes in liver function tests.
Administer as soon as possible prior to the next scheduled dose; do not take 2 doses at the same time to make up for a missed dose.
Males with female partners of reproductive potential should use effective contraception during darolutamide treatment and for 1 week after the last darolutamide dose.
- Baseline CBC w diff, CMP and then every 3 months thereafter.
- PSA every 3 months or as clinically indicated.
Mechanism of Action
Darolutamide is a competitive androgen receptor inhibitor. In addition to androgen binding inhibition, darolutamide also inhibits androgen receptor translocation and androgen receptor-mediated transcription. Keto-darolutamide (active metabolite) has similar in vitro activity to darolutamide. Androgen receptor inhibition results in decreased proliferation of prostate tumor cells and increased apoptosis, leading to a decrease in tumor volume.
In layman’s terms: Nubeqa blocks testosterone from attaching to the androgen receptors, helping to delay the cancer cell from growing.
Store Nubeqa at room temperature. Keep the bottle tightly closed after you first open it. Keep Nubeqa and all medicines out of reach of children.
Tell your healthcare provider about all the medicines you take including prescription and over-the-counter medicines, vitamins, and herbal supplements. Nubeqa may affect the way other medicines work and other medicines may affect how Nubeqa works.
Notify MD of any new or worrisome side effects.